At the same time, empagliflozin was confirmed to increase AMPK activity and to inhibit Sonic Hedgehog Signalling Molecule (SHH) expression in these cells representing the main mechanisms of empagliflozin’s anticancer action against cervical cancer [133]. This evidence concerns the gene SHH and cervical carcinoma.